The US Food and Drug Administration (FDA) said on Friday it had granted emergency use authorization to Eli Lilly and Co's COVID-19 antibody drug for the treatment of patients with mild to moderate disease who are 12 years and older.
The US Food and Drug Administration (FDA) said on Friday it had granted emergency use authorization to Eli Lilly and Co's COVID-19 antibody drug for the treatment of patients with mild to moderate disease who are 12 years and older.
